Airway-specific inducible transgene expression using aerosolized doxycycline.

Area of Science:

• Molecular Biology
• Respiratory Medicine
• Genetics

Background:

• Tetracycline (tet)-regulated systems are crucial for studying gene function but often lack tissue specificity.
• Existing tet-inducible mouse models frequently show unwanted transgene expression in multiple organs.
• This lack of specificity can lead to lethality and hinder research in the target organ.

Purpose of the Study:

• To develop a method for achieving exclusive tet-inducible transgene expression in the airway.
• To enable precise study of airway biology and stem cell function.
• To overcome limitations of systemic doxycycline administration in transgenic mouse models.

Main Methods:

• Optimized dose and duration of aerosolized doxycycline administration in mice.
• Utilized a ubiquitously expressed Rosa26 promoter-driven reverse tet-controlled transcriptional activator (rtTA) element.
• Generated airway basal stem cell-specific transgene expression using a cytokeratin 5 (KRT5)-driven rtTA driver line to activate the Notch pathway.

Main Results:

• Achieved exclusive transgene expression in the airways without affecting cellular composition or proliferation.
• Observed a more robust mucous metaplasia phenotype when Notch pathway was activated via aerosolized doxycycline compared to systemic administration.
• Eliminated off-target phenotypes observed outside the lung with systemic doxycycline delivery.

Conclusions:

• The novel aerosolized doxycycline approach allows for rapid, efficient, and airway-specific transgene expression.
• This method overcomes the limitations of systemic delivery, preventing unwanted phenotypes in other organs.
• Pre-existing transgenic mouse lines can now be effectively utilized for targeted airway biology research.